Law Firms

A class action is challenging the Federal Court's post-trial ruling for Alucobond panel maker 3A Composites and supplier Halifax Vogel.

Swiss drug maker Novartis has lost its bid to have Pharmacor's Valtresto trade mark removed for non use, with an IP Australia delegate finding that an injunction in a fight over the patent for Novartis' heart drug Entresto was an obstacle to using the mark. 

A judge has refused an egg producer's bid for a non-party costs order against Melbourne firm Gordon Legal, saying he was not satisfied the filing of a defective notice was sufficient to invoke the court’s wasted costs jurisdiction.

DC Comics is taking another swing at a Sydney man's bid to register 'kryptonite diet' as a trade mark, arguing he acted "willfully blind" or in bad faith in registering the mark given its sizable reputation in the fictional substance from the Superman franchise.

A judge has accepted that Cbus’ agreement to buy a 50 per cent stake in Sydney’s troubled Halo Tower could fall through if the beleaguered developer behind the project is forced to remain in administration, shooting down a challenge to a DOCA.

A class action by the owners of a residential Sydney building is challenging a ruling for Alucobond panel maker 3A Composites and supplier Halifax Vogel, which found developers were responsible for ensuring the cladding's safety.

Norton Rose Fulbright has advised North Queensland Airports, the owner of Cairns Airport and Mackay Airport, on the $1.085 billion refinancing of its corporate bank debt financing.

Kicking off its case against former Noumi CEO Rory Macleod, ASIC has told the court that Macleod was clearly aware of the "dramatic" difference between actual available stock and what was reported to the market in 2019 and 2020.

A costs assessor that works in class actions said she'll be scrutising whether firms deploy AI to save costs and suggested judges should consider firms' uses of AI when deciding carriage fights.

An executive director at ASIC has said the High Court has “opened the door” for regulators to rely on a new way to prove corporate wrongdoing that does not require establishing that individuals within a company had a wrongful intent or relevant knowledge.